Impact Biomedical (IBO) Valuation Ratios Comparisons to Industry Sector and S&P
CSIMarket Company Name, Ticker, Suppliers, else..
IMPACT BIOMEDICAL INC.  (NYSE: IBO)
 

Impact Biomedical Valuation Comparisons

Select each Category to receive additional Information



Compare IBO Valuations to its Competitors >> Go to Valuation within Major Pharmaceutical Preparations Industry

Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IBO Valuation

 Company Industry Sector S&P 500
Price to earnings PE Ratio (Q3 TTM) 72.17 - - -
Price to Sales (Q3 TTM) 973.57 - - -
Price to Cash Flow (Q3 TTM) - - - -
Price to Free Cash Flow (Q3 TTM) 318.93 -